Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Viruses|October 14, 2011
HIV-1 Entry, Inhibitors, and ResistanceMichael A Lobritz, Annette N Ratcliff, Eric J ArtsCell Host & Microbe|June 18, 2013
Microbial persistence and the road to drug resistanceNadia R Cohen, Michael A Lobritz, James J CollinsCurrent Opinion in HIV and AIDS|March 25, 2011
HIV-1 replicative fitness in elite controllersMichael A Lobritz, Kara G Lassen, Eric J ArtsNano Letters|June 6, 2015
Engineered Phagemids for Nonlytic, Targeted Antibacterial TherapiesRussell J Krom, Prerna Bhargava, Michael A Lobritz, et al.Journal of Virology|May 25, 2007
Natural variation in the V3 crown of human immunodeficiency virus type 1 affects replicative fitness and entry inhibitor sensitivityMichael A Lobritz, Andre J Marozsan, Ryan M Troyer, et al.Cell Metabolism|July 8, 2019
Bacterial Metabolism and Antibiotic EfficacyJonathan M Stokes, Allison J Lopatkin, Michael A Lobritz, et al.The Journal of Biological Chemistry|July 14, 2010
Identification of two APOBEC3F splice variants displaying HIV-1 antiviral activity and contrasting sensitivity to VifKara G Lassen, Silke Wissing, Michael A Lobritz, et al.Molecular Cell|December 12, 2017
Understanding and Sensitizing Density-Dependent Persistence to Quinolone AntibioticsArnaud Gutierrez, Saloni Jain, Prerna Bhargava, et al.Plos One|February 1, 2012
A flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirsKara G Lassen, Andrew M Hebbeler, Darshana Bhattacharyya, et al.Infection and Immunity|February 26, 2005
Translocation and surface expression of lipidated serogroup B capsular Polysaccharide in Neisseria meningitidisYih-Ling Tzeng, Anup K Datta, Cristy A Strole, et al.Pageof 3